Belgian Medical Equipment Stock News

ENXTBR:AZE
ENXTBR:AZETrade Distributors

Assessing Azelis Group After a 51% Slide in 2025: Is Opportunity Emerging?

Wondering if Azelis Group might be an overlooked value pick or if caution is justified? You are not alone. There is a lot to unpack on this stock right now. The share price has taken a notable dive recently, falling 4.3% in the last week and tumbling over 14% in the past month. This brings the year-to-date performance down by a steep 51.3%. These sharp moves are drawing attention, especially since the chemical distributor sector has faced ongoing volatility amidst shifting market conditions...
ENXTBR:AGFB
ENXTBR:AGFBHealthcare Services

Agfa-Gevaert (ENXTBR:AGFB) Valuation in Focus After Q3 Earnings Reveal Wider Quarterly Losses and Sales Dip

Agfa-Gevaert (ENXTBR:AGFB) just released its third quarter and nine-month 2025 earnings results. The report shows that sales have dipped and net losses have widened this quarter compared to the same period last year. See our latest analysis for Agfa-Gevaert. Agfa-Gevaert’s latest trading has been turbulent, with the share price dropping sharply by 20% over the past week and now sitting at $0.625. Looking at the bigger picture, momentum is clearly weak, as the 1-year total shareholder return...
ENXTBR:AGFB
ENXTBR:AGFBHealthcare Services

Agfa-Gevaert (ENXTBR:AGFB) Quarterly Losses: What Do They Reveal About Management’s Turnaround Strategy?

Agfa-Gevaert NV recently reported its third quarter 2025 earnings, revealing sales of €257 million and a net loss of €19 million, both down compared to the same period last year. Although the company's nine-month net loss improved versus the previous year, the quarterly results point to continued operational headwinds affecting Agfa-Gevaert's performance. We'll explore how the combination of declining quarterly sales and a widening net loss is shaping Agfa-Gevaert's investment narrative. AI...
ENXTBR:CENER
ENXTBR:CENERElectrical

Why Cenergy Holdings (ENXTBR:CENER) Is Down 6.9% After Strong Third-Quarter Profit and Sales Growth

Cenergy Holdings reported third-quarter and nine-month 2025 results, delivering sales of €524.27 million and €1.55 billion, and net income of €52.43 million and €147.69 million, respectively, both up from the prior year. Sales and net income growth outpaced the previous year's comparable periods, suggesting the company's operations benefited from strong demand and improved profitability. We'll take a closer look at how Cenergy Holdings' strong revenue and earnings growth this quarter informs...
ENXTBR:UMI
ENXTBR:UMIChemicals

Why Umicore (ENXTBR:UMI) Is Down 13.6% After GBL Halves Its Stake in Accelerated Bookbuild

Belgian holding company GBL recently sold half its stake in Umicore through an accelerated bookbuild, reducing its ownership from 16% to 8% and committing to a 90-day lock-up on its remaining shares. This transaction reflects GBL’s broader plan to streamline its portfolio towards private assets and follows a period of recovery for Umicore’s share price. We'll assess how GBL's sizable stake reduction impacts Umicore’s investment outlook and potential capital structure considerations going...
ENXTBR:SOLB
ENXTBR:SOLBChemicals

Will Solvay's (ENXTBR:SOLB) Rare Earth Deal Reveal Its Edge in Sustainable Supply Chains?

Noveon Magnetics and Solvay recently announced a multi-year supply agreement for light and heavy rare earth oxides, with Solvay providing Neodymium-Praseodymium, Dysprosium, and Terbium oxides, sourced partly from recycled materials, to support Noveon's production of permanent magnets starting in 2026. This collaboration advances a more resilient and sustainable domestic supply chain for rare earth magnets amid ongoing global supply risks and growing demand. The agreement enhances Solvay's...
ENXTBR:LOTB
ENXTBR:LOTBFood

Does Lotus Bakeries' Euronext 150 Inclusion Signal a New Phase for ENXTBR:LOTB Investors?

Lotus Bakeries was recently added to the Euronext 150 Index, highlighting its growing profile among Europe’s largest listed companies. This milestone can influence share demand as index-tracking funds and institutional investors may adjust holdings to include the company. We’ll now explore how inclusion in a major index could impact Lotus Bakeries’ investment narrative and future institutional interest. AI is about to change healthcare. These 32 stocks are working on everything from early...
ENXTBR:KIN
ENXTBR:KINEntertainment

European Stocks Trading Below Estimated Intrinsic Values

As the European market navigates a mixed landscape, with the STOXX Europe 600 Index recently pulling back after reaching new highs and interest rate expectations from the ECB remaining steady, investors are increasingly focused on identifying opportunities among undervalued stocks. In such an environment, a good stock is often characterized by its potential to trade below its estimated intrinsic value, offering room for appreciation as market conditions evolve.
ENXTBR:MELE
ENXTBR:MELESemiconductor

Are We Seeing the First Signs of Operational Strain at Melexis (ENXTBR:MELE)?

Melexis NV reported its third quarter 2025 results, showing sales of €215.29 million and net income of €27.53 million, both significantly lower than the same period a year ago. The contraction in sales and profit indicates the company may be encountering operational or market challenges over the year so far. We’ll examine how reduced earnings for the quarter are influencing Melexis’ investment narrative and outlook for operational momentum. The end of cancer? These 29 emerging AI stocks are...
ENXTBR:AED
ENXTBR:AEDHealth Care REITs

How Raised 2025 Guidance and Solid Results at Aedifica (ENXTBR:AED) Have Changed Its Investment Story

Aedifica announced in late October that it has raised its 2025 earnings guidance and reported solid nine-month results, with sales reaching €271.79 million and net income of €194.12 million. A key highlight is the 3.1% like-for-like rental income growth, reflecting improved operational momentum alongside continued asset rotation and new investment initiatives. We'll explore how the uplifted earnings forecast reinforces Aedifica's investment narrative and signals continued operating momentum...
ENXTBR:CENER
ENXTBR:CENERElectrical

A Fresh Look at Cenergy Holdings (ENXTBR:CENER) Valuation Following Its Recent 71% Shareholder Return

Cenergy Holdings (ENXTBR:CENER) has quietly posted some eye-catching returns over the past year, with shares climbing more than 70%. This strong momentum puts the stock in focus for investors who want to understand what is driving its performance. See our latest analysis for Cenergy Holdings. Cenergy Holdings’ 71% total shareholder return over the past year stands out against a backdrop of accelerating momentum. The company has also seen a 36.7% share price return in the last 90 days and...